Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Agyany Pharma

1 clinical trial

Clinical trial
An Open-Label Pilot Study for Assessing the Safety and Efficacy of High-Dose Ambroxol (HDA) in Newly Diagnosed GBA1 Parkinson Disease (PD)
Status: Recruiting, Estimated PCD: 2025-02-27